Tiziana Life Sciences (Tiziana Life Sciences) Additional Paid-In Capital : $16.49 Mil(As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences Additional Paid-In Capital?

Tiziana Life Sciences's quarterly additional paid-in capital stayed the same from Dec. 2022 ($15.60 Mil) to Jun. 2023 ($15.60 Mil) but then increased from Jun. 2023 ($15.60 Mil) to Dec. 2023 ($16.49 Mil).

Tiziana Life Sciences's annual additional paid-in capital stayed the same from Dec. 2021 ($15.60 Mil) to Dec. 2022 ($15.60 Mil) but then increased from Dec. 2022 ($15.60 Mil) to Dec. 2023 ($16.49 Mil).

Tiziana Life Sciences Additional Paid-In Capital Historical Data

The historical data trend for Tiziana Life Sciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences Additional Paid-In Capital Chart

Tiziana Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

73.92

15.60

16.49

Tiziana Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															15.60	15.60	15.60	15.60	16.49

Tiziana Life Sciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Tiziana Life Sciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tiziana Life Sciences (Tiziana Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

0RP:Germany

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM 11

Website

https://www.tizianalifesciences.com

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.